Drugs / Reconnect
last change Mar 2018 re-read 2 minutes ago

Reconnect

Developed for
autism spectrum disorder

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02543203 Comparator Jul 2015 → Mar 2018 anxiety, autism spectrum disorder Jill Hollway Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Reconnect ClinicalTrials.gov intervention name — accepted as the source's own label NCT02543203